Vistagen Therapeutics (NASDAQ:VTGN) Trading Up 6.9% After Strong Earnings
Vistagen Therapeutics Inc (NASDAQ:VTGN) was up 6.9% during trading on Friday following a stronger than expected earnings report. The stock traded as high as $1.10 and last traded at $1.08, approximately 296,777 shares changed hands during trading. A decline of 6% from the average daily volume of 316,563 shares. The stock had previously closed at $1.01.
The company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.14) by $0.01.
A number of analysts have recently issued reports on VTGN shares. ValuEngine upgraded shares of Vistagen Therapeutics from a “hold” rating to a “buy” rating in a report on Thursday, August 1st. Chardan Capital reiterated a “hold” rating and issued a $0.70 price objective on shares of Vistagen Therapeutics in ...